1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Powers of Buyers
4.3.3. Threat of Substitutes
4.3.4. The Threat of New Entrants
4.3.5. Competitive Rivalry in Industry
4.4. Industry Value Chain Analysis
5. NORTH AMERICA OVER THE COUNTER DRUGS MARKET, BY PRODUCT TYPE
5.1. Introduction
5.2. Cough, Cold, and Flu Products
5.3. Analgesics
5.4. Dermatology Products
5.5. Gastrointestinal Products
5.6. Oral Health Products
5.7. Weight-Loss/Dietary Products
5.8. Ophthalmic Products
5.9. Sleep Aids
5.10. Others
6. NORTH AMERICA OVER THE COUNTER DRUGS MARKET, BY DISTRIBUTION CHANNEL
6.1. Introduction
6.2. Offline
6.3. Online
7. NORTH AMERICA OVER THE COUNTER DRUGS MARKET, BY COUNTRY
7.1. Introduction
7.2. United States
7.3. Canada
7.4. Mexico
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrative
8.3. Mergers, Acquisition, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. COMPANY PROFILES
9.1. Sanofi
9.2. Johnson & Johnson Inc.
9.3. Novartis AG
9.4. Pfizer, Inc.
9.5. GlaxoSmithKline PLC
9.6. Bayer AG
9.7. Perrigo Company Plc
9.8. Takeda Pharmaceutical Company
9.9. Reckitt Benckiser Group PLC
9.10. Boehringer Ingelheim International GmbH